<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00934661</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00006969</org_study_id>
    <nct_id>NCT00934661</nct_id>
  </id_info>
  <brief_title>Low Dose Extended-release Epidural and Lumbar Plexus Block Compared to Lumbar Plexus Block for Total Hip Resurfacing</brief_title>
  <official_title>Low Dose Extended-release Epidural Morphine in Conjunction With Lumbar Plexus Block Versus Lumbar Plexus Block Alone for Total Hip Resurfacing Arthroplasty: A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>EKR Therapeutics, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      At Wake Forest University, the investigators have been using Extended Release Epidural
      Morphine (EREM), since late 2004, as part of multimodal analgesia in patients having
      gynecologic surgeries and hip arthroplasties.

      Hypothesis:

      In patients undergoing a Birmingham total hip arthroplasty (BHA), low dose EREM in
      conjunction with lumbar plexus block (LPB) will be better than lumbar plexus block alone in
      increasing proportion of patients who meet discharge criteria within 24 hours.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Extended release epidural morphine (EREM, DepoDurÂ®: Endo Pharmaceuticals, Chadds Ford PA) has
      been studied and increasingly utilized as a method to allow for the improved post-operative
      analgesia of epidural analgesia without infusions.

      At Wake Forest University, the investigators have been using EREM, since late 2004, as part
      of multimodal analgesia in patients having gynecologic surgeries and hip arthroplasties. The
      investigators initially decreased our dosages from those recommended (15 mg for lower
      extremity surgery and 10-15 mg for abdominal surgery), because side effects (nausea, vomiting
      and hypotension) were felt to be limiting to recovery. The investigators now use 4-7.5 mg in
      most patients, with 7.5 mg being the exception and have achieved better results. For hip
      arthroplasties, the investigators currently use 4-5 mg and have performed two retrospective
      chart reviews on this use; both suggesting that this approach is efficacious. However, these
      doses have not been studied in a prospective, randomized, double blind trial. The
      investigators would like to evaluate the efficacy of this dose of EREM used as part of a
      multimodal regimen. The investigators will compare EREM 4 mg with lumbar plexus block versus
      lumbar plexus block alone, (providing the rest of our multimodal approach for both patients).
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Drug was discontinued by manufacturer
  </why_stopped>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of Hospital Stay After Surgery</measure>
    <time_frame>From surgery day to hospital discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Opioid Consumption</measure>
    <time_frame>96 hours</time_frame>
    <description>Postoperatively, the patients were observed in the post anesthesia care unit (PACU) until regression of sensory levels is demonstrated. They were provided an intravenous (IV) Patient Controlled Analgesia (PCA) and instructions in its use. Morphine 1mg/ml at standard PCA settings (1.5 ml dose, 10 minute lockout interval, 6 ml hourly limit, no basal infusion) were used for postoperative analgesia until discharge plans were made. (Morphine doses were increased in 0.5ml dose increments if the patients were not achieving adequate analgesia.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction Score</measure>
    <time_frame>96 hours</time_frame>
    <description>Verbal satisfaction scores (0-10), higher scores represent better outcomes. Scores will be obtained from patients for 96 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distance Walked at Walking Test</measure>
    <time_frame>96 hours</time_frame>
    <description>Distance walked at walking test. Longer distance walked represent better outcomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Verbal Pain Scores Post-gait</measure>
    <time_frame>1 day post surgery</time_frame>
    <description>Verbal pain scores (0-10), lower scores represent better outcomes. Score will be obtained from patients for 1 day after surgery, post gait active and at rest.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Verbal Pain Scores Post-gait</measure>
    <time_frame>2 Days Post Surgery</time_frame>
    <description>Verbal pain scores (0-10), lower scores represent better outcomes. Score will be obtained from patients for 1 day after surgery, post gait active and at rest.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Verbal Pain Scores Post-gait</measure>
    <time_frame>3 Days Post Surgery</time_frame>
    <description>Verbal pain scores (0-10), lower scores represent better outcomes. Score will be obtained from patients for 1 day after surgery, post gait active and at rest.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Verbal Pain Scores Post-gait</measure>
    <time_frame>4 Days Post Surgery</time_frame>
    <description>Verbal pain scores (0-10), lower scores represent better outcomes. Score will be obtained from patients for 1 day after surgery, post gait active and at rest.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Hip Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Extended Release Epidural Morphine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Four mg (0.4 ml) of EREM will be delivered to the epidural space and flushed with 1 ml of saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Extended Release Epidural Morphine (EREM)</intervention_name>
    <description>A single Four mg (0.4 ml)dose of EREM will be administered into the epidural space and flushed with 1 ml of saline</description>
    <arm_group_label>Extended Release Epidural Morphine</arm_group_label>
    <other_name>Depodur</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>A single epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush</description>
    <arm_group_label>Placebo Group</arm_group_label>
    <other_name>preservative free normal saline</other_name>
    <other_name>sodium chloride</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A primary unilateral Birmingham hip arthroplasty

          -  Men and women 18-65 years

        Exclusion Criteria:

          -  Refusal of regional anesthesia

          -  Laboratory evidence of coagulopathy (platelet count less than 100,000 cells/microliter
             of blood, prothrombin time greater than 12.1 seconds, partial thromboplastin time
             greater than 30 seconds, or international normalized ratio of greater than 1.5)

          -  Allergy to morphine

          -  Obstructive sleep apnea

          -  Body mass index (BMI) greater than 40 kg/m2

          -  Pregnant or lactating

          -  Severe renal or hepatic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pamela C Nagle, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest University Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2009</study_first_submitted>
  <study_first_submitted_qc>July 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2009</study_first_posted>
  <results_first_submitted>November 16, 2017</results_first_submitted>
  <results_first_submitted_qc>December 14, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">January 16, 2018</results_first_posted>
  <last_update_submitted>December 14, 2017</last_update_submitted>
  <last_update_submitted_qc>December 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hip resurfacing</keyword>
  <keyword>hip arthroplasty</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Extended Release Epidural Morphine</title>
          <description>Four mg (0.4 ml) of EREM will be delivered to the epidural space and flushed with 1 ml of saline
Extended Release Epidural Morphine (EREM): A single Four mg (0.4 ml)dose of EREM will be administered into the epidural space and flushed with 1 ml of saline</description>
        </group>
        <group group_id="P2">
          <title>Placebo Group</title>
          <description>The epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush
Placebo: A single epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Failure of Combined/Spinal Epidural</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Extended Release Epidural Morphine</title>
          <description>Four mg (0.4 ml) of EREM will be delivered to the epidural space and flushed with 1 ml of saline
Extended Release Epidural Morphine (EREM): A single Four mg (0.4 ml)dose of EREM will be administered into the epidural space and flushed with 1 ml of saline</description>
        </group>
        <group group_id="B2">
          <title>Placebo Group</title>
          <description>The epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush
Placebo: A single epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="19"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="39"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Length of Hospital Stay After Surgery</title>
        <time_frame>From surgery day to hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Extended Release Epidural Morphine</title>
            <description>Four mg (0.4 ml) of EREM will be delivered to the epidural space and flushed with 1 ml of saline
Extended Release Epidural Morphine (EREM): A single Four mg (0.4 ml)dose of EREM will be administered into the epidural space and flushed with 1 ml of saline</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>The epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush
Placebo: A single epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospital Stay After Surgery</title>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.26" spread="1.29"/>
                    <measurement group_id="O2" value="2.51" spread="2.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Opioid Consumption</title>
        <description>Postoperatively, the patients were observed in the post anesthesia care unit (PACU) until regression of sensory levels is demonstrated. They were provided an intravenous (IV) Patient Controlled Analgesia (PCA) and instructions in its use. Morphine 1mg/ml at standard PCA settings (1.5 ml dose, 10 minute lockout interval, 6 ml hourly limit, no basal infusion) were used for postoperative analgesia until discharge plans were made. (Morphine doses were increased in 0.5ml dose increments if the patients were not achieving adequate analgesia.)</description>
        <time_frame>96 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Extended Release Epidural Morphine</title>
            <description>Four mg (0.4 ml) of EREM will be delivered to the epidural space and flushed with 1 ml of saline
Extended Release Epidural Morphine (EREM): A single Four mg (0.4 ml)dose of EREM will be administered into the epidural space and flushed with 1 ml of saline</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>The epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush
Placebo: A single epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush</description>
          </group>
        </group_list>
        <measure>
          <title>Total Opioid Consumption</title>
          <description>Postoperatively, the patients were observed in the post anesthesia care unit (PACU) until regression of sensory levels is demonstrated. They were provided an intravenous (IV) Patient Controlled Analgesia (PCA) and instructions in its use. Morphine 1mg/ml at standard PCA settings (1.5 ml dose, 10 minute lockout interval, 6 ml hourly limit, no basal infusion) were used for postoperative analgesia until discharge plans were made. (Morphine doses were increased in 0.5ml dose increments if the patients were not achieving adequate analgesia.)</description>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="10.5" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction Score</title>
        <description>Verbal satisfaction scores (0-10), higher scores represent better outcomes. Scores will be obtained from patients for 96 hours after surgery.</description>
        <time_frame>96 hours</time_frame>
        <population>17 participants in the Extended Release Epidural Morphine group and 18 participants in the placebo group provided Verbal satisfaction scores</population>
        <group_list>
          <group group_id="O1">
            <title>Extended Release Epidural Morphine</title>
            <description>Four mg (0.4 ml) of EREM will be delivered to the epidural space and flushed with 1 ml of saline
Extended Release Epidural Morphine (EREM): A single Four mg (0.4 ml)dose of EREM will be administered into the epidural space and flushed with 1 ml of saline</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>The epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush
Placebo: A single epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction Score</title>
          <description>Verbal satisfaction scores (0-10), higher scores represent better outcomes. Scores will be obtained from patients for 96 hours after surgery.</description>
          <population>17 participants in the Extended Release Epidural Morphine group and 18 participants in the placebo group provided Verbal satisfaction scores</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Total Mean and Standard Deviation</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.03" spread="1.46"/>
                    <measurement group_id="O2" value="8.58" spread="1.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Day 1 Surgery</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.12" spread="1.73"/>
                    <measurement group_id="O2" value="8.53" spread="1.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Day 2 Surgery</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.76" spread="1.68"/>
                    <measurement group_id="O2" value="8.94" spread="1.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Day 3 Surgery</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.06" spread="1.20"/>
                    <measurement group_id="O2" value="8.33" spread="1.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Day 4 Surgery</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.18" spread="1.24"/>
                    <measurement group_id="O2" value="8.56" spread="1.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Distance Walked at Walking Test</title>
        <description>Distance walked at walking test. Longer distance walked represent better outcomes</description>
        <time_frame>96 hours</time_frame>
        <population>Different amount of observations were different at each visit. Data for Post Surgery Day 4 for the &quot;Extended Release Epidural Morphine&quot; was not collected.</population>
        <group_list>
          <group group_id="O1">
            <title>Extended Release Epidural Morphine</title>
            <description>Four mg (0.4 ml) of EREM will be delivered to the epidural space and flushed with 1 ml of saline
Extended Release Epidural Morphine (EREM): A single Four mg (0.4 ml)dose of EREM will be administered into the epidural space and flushed with 1 ml of saline</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>The epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush
Placebo: A single epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush</description>
          </group>
        </group_list>
        <measure>
          <title>Distance Walked at Walking Test</title>
          <description>Distance walked at walking test. Longer distance walked represent better outcomes</description>
          <population>Different amount of observations were different at each visit. Data for Post Surgery Day 4 for the &quot;Extended Release Epidural Morphine&quot; was not collected.</population>
          <units>Steps</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Post Surgery Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="168.1" spread="164.2"/>
                    <measurement group_id="O2" value="109.8" spread="117.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Surgery Day 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="206.7" spread="97.1"/>
                    <measurement group_id="O2" value="143.5" spread="97.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Surgery Day 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="200.0" spread="70.7"/>
                    <measurement group_id="O2" value="175.0" spread="132.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post Surgery Day 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="100.0" spread="141.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Verbal Pain Scores Post-gait</title>
        <description>Verbal pain scores (0-10), lower scores represent better outcomes. Score will be obtained from patients for 1 day after surgery, post gait active and at rest.</description>
        <time_frame>1 day post surgery</time_frame>
        <population>16 participants were analyzed in both the Extended Release Epidural Morphine and the Placebo Group for active pain scores. 17 participants overall were analyzed for the Extended Release Epidural Morphine and 18 participants overall were analyzed for the Placebo Group.</population>
        <group_list>
          <group group_id="O1">
            <title>Extended Release Epidural Morphine</title>
            <description>Four mg (0.4 ml) of EREM will be delivered to the epidural space and flushed with 1 ml of saline
Extended Release Epidural Morphine (EREM): A single Four mg (0.4 ml)dose of EREM will be administered into the epidural space and flushed with 1 ml of saline</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>The epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush
Placebo: A single epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush</description>
          </group>
        </group_list>
        <measure>
          <title>Verbal Pain Scores Post-gait</title>
          <description>Verbal pain scores (0-10), lower scores represent better outcomes. Score will be obtained from patients for 1 day after surgery, post gait active and at rest.</description>
          <population>16 participants were analyzed in both the Extended Release Epidural Morphine and the Placebo Group for active pain scores. 17 participants overall were analyzed for the Extended Release Epidural Morphine and 18 participants overall were analyzed for the Placebo Group.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain Score Active</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.44" spread="2.94"/>
                    <measurement group_id="O2" value="7.16" spread="2.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain Score at Rest</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.35" spread="2.5"/>
                    <measurement group_id="O2" value="3.58" spread="2.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Verbal Pain Scores Post-gait</title>
        <description>Verbal pain scores (0-10), lower scores represent better outcomes. Score will be obtained from patients for 1 day after surgery, post gait active and at rest.</description>
        <time_frame>2 Days Post Surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Extended Release Epidural Morphine</title>
            <description>Four mg (0.4 ml) of EREM will be delivered to the epidural space and flushed with 1 ml of saline
Extended Release Epidural Morphine (EREM): A single Four mg (0.4 ml)dose of EREM will be administered into the epidural space and flushed with 1 ml of saline</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>The epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush
Placebo: A single epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush</description>
          </group>
        </group_list>
        <measure>
          <title>Verbal Pain Scores Post-gait</title>
          <description>Verbal pain scores (0-10), lower scores represent better outcomes. Score will be obtained from patients for 1 day after surgery, post gait active and at rest.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain Score Active</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.29" spread="2.23"/>
                    <measurement group_id="O2" value="5.24" spread="2.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain Score at Rest</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.35" spread="1.41"/>
                    <measurement group_id="O2" value="2.41" spread="1.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Verbal Pain Scores Post-gait</title>
        <description>Verbal pain scores (0-10), lower scores represent better outcomes. Score will be obtained from patients for 1 day after surgery, post gait active and at rest.</description>
        <time_frame>3 Days Post Surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Extended Release Epidural Morphine</title>
            <description>Four mg (0.4 ml) of EREM will be delivered to the epidural space and flushed with 1 ml of saline
Extended Release Epidural Morphine (EREM): A single Four mg (0.4 ml)dose of EREM will be administered into the epidural space and flushed with 1 ml of saline</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>The epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush
Placebo: A single epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush</description>
          </group>
        </group_list>
        <measure>
          <title>Verbal Pain Scores Post-gait</title>
          <description>Verbal pain scores (0-10), lower scores represent better outcomes. Score will be obtained from patients for 1 day after surgery, post gait active and at rest.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain Score Active</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.18" spread="2.48"/>
                    <measurement group_id="O2" value="5.06" spread="2.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain Score at Rest</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.59" spread="2.29"/>
                    <measurement group_id="O2" value="2.78" spread="2.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Verbal Pain Scores Post-gait</title>
        <description>Verbal pain scores (0-10), lower scores represent better outcomes. Score will be obtained from patients for 1 day after surgery, post gait active and at rest.</description>
        <time_frame>4 Days Post Surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Extended Release Epidural Morphine</title>
            <description>Four mg (0.4 ml) of EREM will be delivered to the epidural space and flushed with 1 ml of saline
Extended Release Epidural Morphine (EREM): A single Four mg (0.4 ml)dose of EREM will be administered into the epidural space and flushed with 1 ml of saline</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>The epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush
Placebo: A single epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush</description>
          </group>
        </group_list>
        <measure>
          <title>Verbal Pain Scores Post-gait</title>
          <description>Verbal pain scores (0-10), lower scores represent better outcomes. Score will be obtained from patients for 1 day after surgery, post gait active and at rest.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain Score Active</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.59" spread="2.15"/>
                    <measurement group_id="O2" value="5.00" spread="2.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain Score at Rest</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.88" spread="2.26"/>
                    <measurement group_id="O2" value="2.94" spread="2.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Extended Release Epidural Morphine</title>
          <description>Four mg (0.4 ml) of EREM will be delivered to the epidural space and flushed with 1 ml of saline
Extended Release Epidural Morphine (EREM): A single Four mg (0.4 ml)dose of EREM will be administered into the epidural space and flushed with 1 ml of saline</description>
        </group>
        <group group_id="E2">
          <title>Placebo Group</title>
          <description>The epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush
Placebo: A single epidural injection will be a placebo consisting of 0.4 ml of saline followed by 1 ml saline flush</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_vocab>Hypotension</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension</sub_title>
                <description>Subject experienced hypotension during the operative period, continued to experience hypotension during the immediate recovery period and continued on the neosynephrine infusion as well as receiving blood products and colloids for fluid resuscitation</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Pamela Nagle Assistant Professor</name_or_title>
      <organization>Anesthesiology</organization>
      <phone>336-716-7180</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

